Clinical Trials Directory

Trials / Unknown

UnknownNCT01829139

Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones

A Prospective Multicenter Comparative Study for Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Soon Chun Hyang University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

In patients with gallbladder in situ after complete removal of common bile duct (CBD) stones, there is no definite guideline for the management of remnant acalculous gallbladder. This study was planned to evaluate the efficacy of choleretic agents in those patients comparing with non-treatment group during short (2 years) and long-term (5 to 10 years) period. So that, the investigators want to establish the treatment guideline in gallbladder in situ without definite stones following complete removal of CBD stones. Second, the protective or preventive effect of choleretics may be defined.

Conditions

Timeline

Start date
2012-03-01
Primary completion
2014-02-01
Completion
2021-12-01
First posted
2013-04-11
Last updated
2013-04-11

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01829139. Inclusion in this directory is not an endorsement.

Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones (NCT01829139) · Clinical Trials Directory